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E D I TOR I A L
Introduction to Special Issue: 2016 Translational Medicine and
Bioengineering Conference
Bioengineering & Translational Medicine was launched in 2016 with the
goal to highlight the scientific and technological issues relevant to the
translational challenges of bioengineering science and technologies. Clin-
ical translation of promising biological technologies can have a transfor-
mative impact on human health. Several advances in bioengineering
have already had a huge impact in the diagnosis and treatment of human
diseases. However, with rapid development of new technologies coming
down the innovation pipeline, it is critical to develop streamlined path-
ways for their eventual translation to the clinic. The journal has been
met with significant excitement by the scientific community.
Last year saw another milestone for AIChE and SBE in the field of Bio-
engineering and TranslationalMedicine. Specifically, a new scientificmeeting,
Translational Medicine and Bioengineering Conference, was launched to
further highlight the significance of this topic. The conference was organ-
ized on November 12 and 13, 2016 in San Francisco, CA (https://www.
aiche.org/sbe/conferences/translational-medicine-and-bioengineering-
conference/2016), just ahead of AIChE’s annual meeting. It brought
together scientists, bioengineers, leaders from industry, and various stake-
holders as part of a single-track conference format at the interface of inno-
vative biological technologies and clinical translation.
Professors Ravi Kane and Mark Prausnitz from Georgia Tech were
the inaugural co-chairs of the conference, and along with individual
session co-chairs, organized an exciting program that brought forth
cutting-edge translational bioengineering technologies in biopharma-
ceuticals, gene and drug delivery, immunoengineering, biomanufactur-
ing, and stem cells and regenerative medicine in technical sessions
dedicated to each of these topics. Each session had a strong mix of
invited speakers as well as contributed platform presentations. The
program also included a panel discussion on entrepreneurship in which
entrepreneurs from academia, industrial leaders, and technology
transfer specialists shared invaluable thoughts and experiences in the
path traveled from the lab bench to the clinic. The conference provided
a unique platform for bioengineers to present innovative advances at
different stages of the translational spectrum.
This special issue of BioTM features contributions from some of
the participants in this conference as well as other scientists in the
field. Prof. Christopher Jewell (U. Maryland) and coworkers review the
latest advances in immunomodulatory biomaterials for applications
in regenerative medicine and tissue engineering.1 Prof. Subbu
Venkatraman (Nanyang Technological University, Singapore) and
coworkers’ timely review on translation of stents and occluders covers
key advances of these devices in in cardiovascular medicine.2 In addi-
tion to these outstanding review articles, this special issue also includes
six research reports. Prof. Eniola-Adefeso (U. Michigan) and coworkers
report a detailed molecular-level study of adhesion of PLGA nanopar-
ticles in human blood flow, with significant implications for drug deliv-
ery.3 Prof. Robert E. Atkins Jr. (U. Delaware) and coworkers describe
the use of a hydrogel for modulating the elasticity or arteries following
isolation using skeletonization.4 Prof. Jacob Elmer (U. Villanova) and
coworkers compare different extracellular oxygen carriers from inverte-
brates as potential blood substitutes.5 Prof. Steven Jay (U. Maryland)
and coworkers report the impact of biomanufacturing-related operat-
ing parameters on the production and biological activity of extracellular
vesicles derived from mesenchymal stem cells.6 Prof. Sean Palecek
(U. Wisconsin) and coworkers describe the generation of endothelial
cells from human pluripotent stem cell-derived epicardial cells.7
Prof. Benjamin Keselowsky (U. Florida) and coworkers report the
development of blend polymeric microparticles for T-cell activation.8
We invite you to read the excellent array of review and research
articles in this issue of Bioengineering and Translational Medicine.
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